Browse All

Current Filters

CLEAR FILTER x

TITLE

Program Number:

Safety of Non-MS Biologics in Patients with Multiple Sclerosis: A Multi-center Retrospective Study of MS Patients with Co-morbid Autoimmune Conditions

Author:Madill, Evan   Lenzi, Kerry   Galetta, Kristin   Lincoln, John   Longbrake, Erin   Von Geldern, Gloria   Sloane, Jacob   Coban, Hamza   Wallach, Asya   Gutman, Josef   Le, Nancy   Akers, Carolyn   Vij, Raveena   Bacon, Tamar   Naydovich, Laura   Pileggi, Caitlin   Xi, Jeffrey   de Freitas Dias, Bruna   Hobbs, Joshua   Balshi, Alexandra   Picone, Mary   Vonderhaar, Josephine   Kantor, Daniel   Bhattacharyya, Shamik   Kister, Ilya   

Session Name:S40: Multiple Sclerosis: Clinical Trials/Science and Real-world Evidence  

Topic:Multiple Sclerosis  

Program Number:Multiple Sclerosis  

Author Institution:University of Washington, Seattle, WA  University of Pennsylvania, Philadelphia, PA  Stanford University, PALO ALTO, CA  McGovern Medical School, UTHealth, Houston, TX  Yale University, New Haven, CT  Beth Israel Deaconess Medical Center, Boston, MA  University of Connecticut, Farmington, CT  Holy Name, Teaneck, NJ  NYU Langone Ambulatory Care Center East Meadow, East Meadow, NY  University of Iowa, IA  New York University Grossman School of Medicine, NY  Beth Israel Deaconess Medical Center, Brookline, MA  Medical Partnership 4 MS+, Coconut Creek, FL  Brigham and Women'S Hospital, Boston, MA  

What Happens When Older MS Patients Stop Their Anti-CD20? A Two-center Retrospective Study

Author:Omari, Mirza   Wolf, Andrew   Alvarez, Enrique   Manini, Lyla   Corboy, John   Kister, Ilya   

Session Name:S40: Multiple Sclerosis: Clinical Trials/Science and Real-world Evidence  

Topic:Multiple Sclerosis  

Program Number:Multiple Sclerosis  

Author Institution:New York University, Langone Medical Center, New York, NY  University of Colorado , Aurora, CO  University of Colorado, Aurora, CO  

Long-term Follow-up of Multiple Sclerosis Patients Treated With Cladribine Tablets as De-escalation Strategy From AntiCD20

Author:Gobbi, Claudio   Sacco, Rosaria   Disanto, Giulio   Mallucci, Giulia   Masciullo, Roberto   Maleska, Aleksandra   Kuhle, Jens   Zecca, Chiara   

Session Name:S40: Multiple Sclerosis: Clinical Trials/Science and Real-world Evidence  

Topic:Multiple Sclerosis  

Program Number:Multiple Sclerosis  

Author Institution:Istituto Neurocentro della Svizzera Italiana (INSI), Ospedale Regionale di Lugano, Lugano, Switzerland and Faculty of biomedical Sciences, Università della Svizzera Italiana, Via Buffi 13, 6900 Lugano, Switzerland, Lugano, Switzerland  Istituto Neurocentro della Svizzera Italiana (INSI), Ospedale Regionale di Lugano, Lugano, Switzerland., Switzerland  Istituto Neurocentro della Svizzera Italiana (INSI), Ospedale Regionale di Lugano, Lugano, Switzerland. Department of Neuroradiology, Neurocenter of Southern Switzerland, EOC, Lugano, Switzerland of biomedical Sciences, Università della Svizzera Italiana, Via Buffi 13, 6900 Lugano, Switzerland, Swit  Multiple Sclerosis Centre and Research Centre for Clinical Neurimmunology and Neuroscience (RC2NB), Neurology, Departments of Biomedicine and Clinical Research, University Hospital and University of Basel, Basel, Switzerland, Switzerland  

The Bilingual VISIBL- MS Tool Captures Early Clinical Symptoms at the Onset of Multiple Sclerosis (MS) in a Diverse Urban Population

Author:Viswanathan, Sai   Vazquez, Michael   Gutierrez, Carlos   Nelson, Karen   Imitola, Jaime   

Session Name:S40: Multiple Sclerosis: Clinical Trials/Science and Real-world Evidence  

Topic:Multiple Sclerosis  

Program Number:Multiple Sclerosis  

Author Institution:University of Connecticut, Avon, CT  University of Connecticut, Brooklyn, NY  UConn Health MS center, CT  UConn Health MS center, Farmington, CT  

Efficacy and Safety of Tolebrutinib Versus Placebo in Primary Progressive Multiple Sclerosis: Results from the Phase Three PERSEUS Trial

Author:Fox, Robert   Bar-Or, Amit   Vermersch, Patrick   Oreja Guevara, Celia   Traboulsee, Anthony   Giovannoni, Gavin   Syed, Sana   Sun, Furong   Salloum, Naji   Turner, Timothy   Wallstroem, Erik   Reich, Daniel   

Session Name:PL6: Contemporary Clinical Issues Plenary Session  

Topic:Multiple Sclerosis  

Program Number:Multiple Sclerosis  

Author Institution:Cleveland Clinic, Cleveland, OH  University of Pennsylvania, Philadelphia, PA  University of Lille, Lille, France  Instituto de Investigación Sanitaria del Hospital Clínico San Carlos, Madrid, Spain  University of British Columbia, Vancouver, BC, Canada  Queen Mary University London, London, United Kingdom  Sanofi , Cambridge, MA  Sanofi, Morristown, NJ  Sanofi, CHILLY-MAZARIN, France  Sanofi, Cambridge, MA  Translational Neuroradiology Section, National Institutes of Health, Bethesda, MD